Agenus, Inc. (AGEN)
7.67
+0.13
(+1.72%)
USD |
NASDAQ |
Oct 09, 16:00
7.655
-0.02
(-0.20%)
After-Hours: 20:00
Agenus Free Cash Flow (Quarterly) : -31.20M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -31.20M |
| March 31, 2026 | -35.95M |
| December 31, 2025 | -16.62M |
| September 30, 2025 | -14.74M |
| June 30, 2025 | -20.22M |
| March 31, 2025 | -25.62M |
| December 31, 2024 | -28.72M |
| September 30, 2024 | -53.30M |
| June 30, 2024 | -38.64M |
| March 31, 2024 | -38.23M |
| December 31, 2023 | -35.23M |
| September 30, 2023 | -68.68M |
| June 30, 2023 | -69.88M |
| March 31, 2023 | -60.37M |
| December 31, 2022 | -61.68M |
| September 30, 2022 | -47.91M |
| June 30, 2022 | -61.90M |
| March 31, 2022 | -56.94M |
| December 31, 2021 | -31.89M |
| September 30, 2021 | 108.99M |
| June 30, 2021 | -57.83M |
| March 31, 2021 | -42.94M |
| December 31, 2020 | -36.42M |
| September 30, 2020 | -32.50M |
| June 30, 2020 | -38.49M |
| Date | Value |
|---|---|
| March 31, 2020 | -35.15M |
| December 31, 2019 | -32.84M |
| September 30, 2019 | -28.62M |
| June 30, 2019 | -36.96M |
| March 31, 2019 | 75.09M |
| December 31, 2018 | -36.41M |
| September 30, 2018 | -25.32M |
| June 30, 2018 | -31.21M |
| March 31, 2018 | -41.74M |
| December 31, 2017 | -26.62M |
| September 30, 2017 | -27.11M |
| June 30, 2017 | -28.37M |
| March 31, 2017 | -15.25M |
| December 31, 2016 | -20.44M |
| September 30, 2016 | -28.85M |
| June 30, 2016 | -20.12M |
| March 31, 2016 | -23.07M |
| December 31, 2015 | -20.36M |
| September 30, 2015 | -19.31M |
| June 30, 2015 | -14.07M |
| March 31, 2015 | 2.972M |
| December 31, 2014 | -12.22M |
| September 30, 2014 | -8.441M |
| June 30, 2014 | -10.09M |
| March 31, 2014 | -10.30M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 236.72M |
| Novavax, Inc. | -73.40M |
| AVITA Medical, Inc. | -3.742M |
| Iovance Biotherapeutics, Inc. | -66.28M |
| Amgen, Inc. | 3.489B |